Scientists say the test could predict the disease with 90% accuracy
Jon Hamilton, "Alzheimer's Blood Test Raises Ethical Questions", NPR Morning Edition 3/9/2014: An experimental blood test can identify people in their 70s who are likely to develop Alzheimer's disease within two or three years. The test is accurate more than 90 percent of the time, scientists reported Sunday in Nature Medicine. The finding could lead to a quick […]
A blood test that can predict with greater than 90 percent accuracy if a healthy person will develop mild cognitive impairment or Alzheimer's disease within three years has been discovered and validated.
What are the signs and symptoms that a person living with Alzheimer’s disease is eligible for hospice care? Marie Marley Alzheimer's Reading Room What happens when your loved one is ready for hospice care but you aren’t? I’d like to share my personal experience with this situation with you. Show More Summary
First things first. The news that there's a test for Alzheimer's which is 90 per cent accurate does not mean that, if you take the test and it says you're positive, you're 90 per cent likely to develop Alzheimer's disease. Graeme Archer has talked about this stuff in the past, much more knowledgeably than I [...]
Blood test can predict Alzheimer’s: study (via AFP) Researchers in the United States say they have developed a prototype blood test that can tell with 90-percent accuracy whether a healthy person will develop Alzheimer’s disease within three years. The test looks for 10 signatures of fatty proteins called…
There's word of a possible early diagnostic blood test for Alzheimer's. A large team (mostly from Georgetown and Rochester) has published a paper in Nature Medicine on their search for lipid-based markers of incipient disease. They say...Show More Summary
US medical researchers have developed a blood test which predicts with 90 percent accuracy if an individual will develop Alzheimer's disease or mild cognitive impairment within three years. The test, which looks for a set of ten lipid...Show More Summary
In a first-of-its-kind study, researchers have developed a blood test for Alzheimer's disease that predicts with astonishing accuracy whether a healthy person will develop the disease. The test caught Alzheimer's before the patient even had symptoms, suggesting that the disease process begins long before people's memories start failing. Show More Summary
Alzheimer's disease represents the most common form of dementia, with the early stages of the disease generally characterized with short term memory loss and learning difficulties that increase in severity as the patient progresses in age. Show More Summary
We have an epidemic of Alzheimer’s disease—epidemic, that’s the only word for it. And there’s a humanitarian and political opportunity here, but only if someone seizes it. Here at Breitbart News, we might ask: Can conservatives and libertarians...Show More Summary
Alzheimer's disease (AD) and other forms of dementia have evaded successful therapies though considerable research has focused on their development. One reason is that they have also evaded prediction, not even being recognized until...Show More Summary
WASHINGTON — Researchers have discovered and validated a blood test that can predict with greater than 90 percent accuracy if a healthy person will develop mild cognitive impairment or Alzheimer's disease within three years. Described...Show More Summary
There is evidence that the brain changes associated with Alzheimer's disease begin many years before clinical symptoms like memory loss and mental decline emerge. With this in mind, biomarkers of these changes could be valuable ways to identify individuals at the "preclinical" stage, which is early enough for brain-preserving treatment to be effective.
The progression of Alzheimer's may slow once symptoms appear and do significant damage, according to a study investigating an inherited form of the disease. Through an international study, researchers have found rapid neuronal damage begins 10 to 20 years before symptoms appear. Show More Summary
Reelin, a crucial protein for adult brain plasticity, recovers cognitive functions in mice with Alzheimer’s disease. This is one of the main results a new study. Alzheimer's disease is a neurodegenerative disease characterized by progressive cognitive deficits, synaptic loss and neuronal death. Show More Summary
Harvard stem cell scientists have successfully converted skins cells from patients with early-onset Alzheimer's into the types of neurons that are affected by the disease, making it possible for the first time to study this leading form of dementia in living human cells. This may also make it possible to develop therapies far more quickly and accurately than before.
Researchers at Harvard University's Stem Cell Institute have converted skin cells of patients with early-onset Alzheimer's disease into neurons that are typically affected by the disease. This is the first time researchers have been able to study the disease in human, rather than animal, cells, and this ability enhances the possibilities for earlier treatments for the disease.
New evidence suggests that deaths from Alzheimer's are 5 to 6 times higher than previously reported by the Centers for Disease Contol and death certificates. Alzheimer's Reading Room Subscribe to the Alzheimer's Reading Room Email: Alzheimer’s...Show More Summary
A study from researchers at Rush University Medical Center suggests Alzheimer's disease may be a much larger cause of death than previously thought, ranking just behind heart disease and cancer. Alzheimer's Reading Room “Alzheimer’s disease and other dementias are under-reported on death certificates and medical records,” said study author Bryan D. Show More Summary